Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Repeated use of platelet-rich plasma in rats caused increased pain sensitivity.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Nrf-2-modified stem cells from hair follicles significantly improve ulcerative colitis in rats.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Early diagnosis and quick treatment improve life quality for FFA patients.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Melatonin and photobiomodulation are effective for treating Alopecia X in German Spitz dogs.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

A horse in Brazil had seasonal hair loss possibly linked to light exposure and melatonin levels.

Three related Persian cats have a rare, likely hereditary skin condition causing hair loss and poor coat quality, with limited treatment options.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

A young man's hair loss was the only sign of syphilis, which improved after treatment.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Adapalene 0.1% effectively reduces acne by decreasing comedones and altering skin properties.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.